Urolithiasis is a prevalent global health burden characterized by high recurrence rates and marked sexual dimorphism. While the gut microbiome's role in oxalate degradation is established, the functional capacity of the local urinary microbiome remains largely unexplored. This study investigated the composition and function of the urinary microbiome in 40 healthy volunteers and 61 urolithiasis patients using 16S rRNA amplicon sequencing, alongside a retrospective analysis of stone composition in 2027 patients. We identified a diverse, ecologically structured microbiome in healthy urine dominated by genera such as Lactobacillus, Streptococcus, and Gardnerella. Significant sex-dependent differences were observed: While males exhibited higher microbial α-diversity, females demonstrated a distinct compositional structure with superior predicted functional capacity for stone degradation. Specifically, the female microbiome was enriched with enzymes including oxalyl-CoA decarboxylase, formyl-CoA transferase, urate oxidase, and purine nucleosidase. Correlation analysis identified Lactobacillus, Enterococcus, and Gardnerella as key contributors to this litholytic potential. Conversely, urolithiasis patients displayed significant dysbiosis, characterized by disrupted microbial networks and a marked reduction in these stone-degrading enzymes. Clinical data supported these findings, revealing a significantly higher prevalence of uric acid stones in males, consistent with their lower microbial degradation capacity. These findings suggest that the healthy urinary microbiome functions as a metabolically active defense system against stone formation. The observed sex-specific variations in microbial composition and enzymatic function provide a novel mechanistic explanation for the epidemiological sex disparities in urolithiasis, highlighting the urinary–kidney axis as a potential therapeutic target.
Citation: Ying Li, Chengqiang Mo, Yun Xie, Zhixin Huang, Lingwu Chen, Xinqiang Xie, Junhang Luo, Shixuan Huang, Shuangjian Jiang, Tianhao Zhang, Jumei Zhang, Rongpei Wu, Qingping Wu. The stone-degrading metabolic potential of the urinary microbiome: Sexual dimorphism and dysbiosis in urolithiasis[J]. AIMS Microbiology, 2026, 12(3): 595-609. doi: 10.3934/microbiol.2026026
Urolithiasis is a prevalent global health burden characterized by high recurrence rates and marked sexual dimorphism. While the gut microbiome's role in oxalate degradation is established, the functional capacity of the local urinary microbiome remains largely unexplored. This study investigated the composition and function of the urinary microbiome in 40 healthy volunteers and 61 urolithiasis patients using 16S rRNA amplicon sequencing, alongside a retrospective analysis of stone composition in 2027 patients. We identified a diverse, ecologically structured microbiome in healthy urine dominated by genera such as Lactobacillus, Streptococcus, and Gardnerella. Significant sex-dependent differences were observed: While males exhibited higher microbial α-diversity, females demonstrated a distinct compositional structure with superior predicted functional capacity for stone degradation. Specifically, the female microbiome was enriched with enzymes including oxalyl-CoA decarboxylase, formyl-CoA transferase, urate oxidase, and purine nucleosidase. Correlation analysis identified Lactobacillus, Enterococcus, and Gardnerella as key contributors to this litholytic potential. Conversely, urolithiasis patients displayed significant dysbiosis, characterized by disrupted microbial networks and a marked reduction in these stone-degrading enzymes. Clinical data supported these findings, revealing a significantly higher prevalence of uric acid stones in males, consistent with their lower microbial degradation capacity. These findings suggest that the healthy urinary microbiome functions as a metabolically active defense system against stone formation. The observed sex-specific variations in microbial composition and enzymatic function provide a novel mechanistic explanation for the epidemiological sex disparities in urolithiasis, highlighting the urinary–kidney axis as a potential therapeutic target.
| [1] | Zi H, Liu MY, Luo LS, et al. (2024) Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res 11: 64. https://doi.org/10.1186/s40779-024-00569-w |
| [2] |
Chewcharat A, Curhan G (2021) Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis 49: 27-39. https://doi.org/10.1007/s00240-020-01210-w
|
| [3] |
Wang Z, Zhang Y, Zhang JW, et al. (2021) Recent advances on the mechanisms of kidney stone formation (Review). Int J Mol Med 48: 149. https://doi.org/10.3892/ijmm.2021.4982
|
| [4] |
Hong SY, Xia QD, Yang YY, et al. (2023) The role of microbiome: A novel insight into urolithiasis. Crit Rev Microbiol 49: 177-196. https://doi.org/10.1080/1040841X.2022.2045899
|
| [5] |
Arvans D, Jung Y, Antonopoulos D, et al. (2017) Oxalobacter formigenes-derived bioactive factors stimulate oxalate transport by intestinal epithelial cells. J Am Soc Nephrol 28: 876-887. https://doi.org/10.1681/ASN.2016020132
|
| [6] |
Barnett C, Nazzal L, Goldfarb DS, et al. (2016) The presence of Oxalobacter formigenes in the microbiome of healthy young adults. J Urol 195: 499-506. https://doi.org/10.1016/j.juro.2015.08.070
|
| [7] |
Jones-Freeman B, Chonwerawong M, Marcelino VR, et al. (2021) The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol 14: 779-792. https://doi.org/10.1038/s41385-020-00372-5
|
| [8] |
Sorokin I, Mamoulakis C, Miyazawa K, et al. (2017) Epidemiology of stone disease across the world. World J Urol 35: 1301-1320. https://doi.org/10.1007/s00345-017-2008-6
|
| [9] |
Huynh LM, Dianatnejad S, Tofani S, et al. (2020) Metabolic diagnoses of recurrent stone formers: Temporal, geographic and gender differences. Scand J Urol 54: 456-462. https://doi.org/10.1080/21681805.2020.1840430
|
| [10] |
Türk C, Petřík A, Sarica K, et al. (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69: 475-482. https://doi.org/10.1016/j.eururo.2015.07.041
|
| [11] |
Siener R, Buchholz N, Daudon M, et al. (2016) Quality assessment of urinary stone analysis: Results of a multicenter study of laboratories in Europe. PLoS One 11: e0156606. https://doi.org/10.1371/journal.pone.0156606
|
| [12] |
Skolarikos A, Neisius BSA, Jung H, et al. (2024) Metabolic evaluation and recurrence prevention for urinary stone patients: An EAU guidelines update. Eur Urol 86: 343-363. https://doi.org/10.1016/j.eururo.2024.05.029
|
| [13] |
Lu Y, Zhou G, Ewald J, et al. (2023) MicrobiomeAnalyst 2.0: Comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res 51: 310-318. https://doi.org/10.1093/nar/gkad407
|
| [14] |
Custer GF, Gans M, Diepen LTAv, et al. (2023) Comparative analysis of core microbiome assignments: Implications for ecological synthesis. mSystems 8: e0106622. https://doi.org/10.1128/msystems.01066-22
|
| [15] |
Shannon P, Markiel A, Ozier O, et al. (2003) Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504. https://doi.org/10.1101/gr.1239303
|
| [16] |
Langille MG, Zaneveld J, Caporaso JG, et al. (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821. https://doi.org/10.1038/nbt.2676
|
| [17] |
Segata N, Izard J, Waldron L, et al. (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12: R60. https://doi.org/10.1186/gb-2011-12-6-r60
|
| [18] |
Dong Q, Nelson DE, Toh E, et al. (2011) The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One 6: e19709. https://doi.org/10.1371/journal.pone.0019709
|
| [19] |
Bradshaw CS, Tabrizi SN, Read TR, et al. (2006) Etiologies of nongonococcal urethritis: Bacteria, viruses, and the association with orogenital exposure. J Infect Dis 193: 336-345. https://doi.org/10.1086/499434
|
| [20] |
Siddiqui H, Nederbragt AJ, Lagesen K, et al. (2011) Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 11: 244. https://doi.org/10.1186/1471-2180-11-244
|
| [21] |
Fouts DE, Pieper R, Szpakowski S, et al. (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10: 174. https://doi.org/10.1186/1479-5876-10-174
|
| [22] |
Vendrell JA, Henry S, Cabello-Aguilar S, et al. (2022) Determination of the optimal bacterial DNA extraction method to explore the urinary microbiota. Int J Mol Sci 23: 1336. https://doi.org/10.3390/ijms23031336
|
| [23] |
Mahony J, Chong S, Jang D, et al. (1998) Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: Identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 36: 3122-3126. https://doi.org/10.1128/JCM.36.11.3122-3126.1998
|
| [24] |
Khan G, Kangro HO, Coates PJ, et al. (1991) Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol 44: 360-365. https://doi.org/10.1136/jcp.44.5.360
|
| [25] |
Liu F, Zhang N, Wu Y, et al. (2020) The pelvis urinary microbiome in patients with kidney stones and clinical associations. BMC Microbiol 20: 336. https://doi.org/10.1186/s12866-020-01992-4
|
| [26] |
Pearce MM, Hilt EE, Rosenfeld AB, et al. (2014) The female urinary microbiome: A comparison of women with and without urgency urinary incontinence. mBio 5: e01283-01214. https://doi.org/10.1128/mBio.01283-14
|
| [27] |
Wu P, Chen Y, Zhao J, et al. (2017) Urinary microbiome and psychological factors in women with overactive bladder. Front Cell Infect Microbiol 7: 488. https://doi.org/10.3389/fcimb.2017.00488
|
| [28] |
Nobels A, Van Marcke C, Jordan BF, et al. (2025) The gut microbiome and cancer: From tumorigenesis to therapy. Nat Metab 7: 895-917. https://doi.org/10.1038/s42255-025-01287-w
|
| [29] |
Snelson M, Muralitharan RR, Liu CF, et al. (2025) Gut-heart axis: The role of gut microbiota and metabolites in heart failure. Circ Res 136: 1382-1406. https://doi.org/10.1161/CIRCRESAHA.125.325516
|
| [30] |
Mager LF, Burkhard R, Pett N, et al. (2020) Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369: 1481-1489. https://doi.org/10.1126/science.abc3421
|
| [31] |
Liu Q, Liu Q, Meng H, et al. (2020) Staphylococcus epidermidis contributes to healthy maturation of the nasal microbiome by stimulating antimicrobial peptide production. Cell Host Microbe 27: 68-78. https://doi.org/10.1016/j.chom.2019.11.003
|
| [32] |
Tamborino F, Cicchetti R, Mascitti M, et al. (2024) Pathophysiology and main molecular mechanisms of urinary stone formation and recurrence. Int J Mol Sci 25: 3075. https://doi.org/10.3390/ijms25053075
|
| [33] |
Mitchell T, Kumar P, Reddy T, et al. (2019) Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol 316: F409-F413. https://doi.org/10.1152/ajprenal.00373.2018
|
| [34] |
Kulsoom, Ahmad S, Urwa, et al. (2025) Associations between clinical, biochemical, and nutritional factors in kidney stone formation and recurrence. Urolithiasis 53: 112. https://doi.org/10.1007/s00240-025-01784-3
|
| [35] |
Barr-Beare E, Saxena V, Hilt EE, et al. (2015) The interaction between Enterobacteriaceae and calcium oxalate deposits. PLoS One 10: e0139575. https://doi.org/10.1371/journal.pone.0139575
|
| [36] |
Iswantini D, Nurhidayat N, Trivadila, et al. (2014) Activity and stability of uricase from Lactobacillus plantarum immobilizated on natural zeolite for uric acid biosensor. Pak J Biol Sci 17: 277-281. https://doi.org/10.3923/pjbs.2014.277.281
|
| [37] |
Khan A (2018) Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol 50: 799-806. https://doi.org/10.1007/s11255-018-1849-2
|